Laboratory Corporation of America Holdings (LH) - Financial and Strategic SWOT Analysis Review

Date: April 29, 2014
Pages: 51
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L263FF2C92FEN
Leaflet:

Download PDF Leaflet

Laboratory Corporation of America Holdings (LH) - Financial and Strategic SWOT Analysis Review
Laboratory Corporation of America Holdings (LH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Laboratory Corporation of America Holdings (LabCorp) is an independent clinical laboratory company engaged in developing and commercializing a wide range of new diagnostic technologies and testing services. The company divides its products into two reportable segments namely the Clinical diagnostics laboratory segment , which includes core testing as well as genomic and esoteric testing, and Others, which includes the Company’s non-U.S. clinical diagnostic laboratory operations in Ontario.

Laboratory Corporation of America Holdings Key Recent Developments

Apr 28, 2014: Laboratory Corporation of America Holdings Announces 2014 First Quarter Results and Updates 2014 Guidance
Mar 31, 2014: LabCorp Announces Changes to Board of Directors
Mar 25, 2014: LabCorp Announces Appointment of Chief Financial Officer
Feb 24, 2014: LabCorp Announces the Availability of Thermo Scientific ImmunoCAP Allergy Testing Products
Feb 07, 2014: Laboratory Corporation of America Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Laboratory Corporation of America Holdings - Key Facts
Laboratory Corporation of America Holdings - Key Employees
Laboratory Corporation of America Holdings - Key Employee Biographies
Laboratory Corporation of America Holdings - Major Products and Services
Laboratory Corporation of America Holdings - Medical Equipment Pipeline Products Data
Laboratory Corporation of America Holdings Pipeline Products by Equipment Type
Laboratory Corporation of America Holdings Pipeline Products by Development Stage
Laboratory Corporation of America Holdings - History
Laboratory Corporation of America Holdings - Company Statement
Laboratory Corporation of America Holdings - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Laboratory Corporation of America Holdings - Business Description
Laboratory Corporation of America Holdings - Corporate Strategy
Laboratory Corporation of America Holdings - SWOT Analysis
SWOT Analysis - Overview
Laboratory Corporation of America Holdings - Strengths
Strength - Consistent Growth
Strength - Broad Service Portfolio
Strength - Strong Operational Network
Laboratory Corporation of America Holdings - Weaknesses
Weakness - Involvement in Litigations
Weakness - Increasing Debt
Laboratory Corporation of America Holdings - Opportunities
Opportunity - Growing Clinical Laboratory Testing Industry
Opportunity - Introduction of New Tests
Opportunity - Inorganic Growth Strategies
Laboratory Corporation of America Holdings - Threats
Threat - Highly Competitive Market
Threat - Rapid Technological Change
Threat - Stringent Government Regulations
Laboratory Corporation of America Holdings - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Type, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Laboratory Corporation of America Holdings, Recent Developments
Apr 28, 2014: Laboratory Corporation of America Holdings Announces 2014 First Quarter Results and Updates 2014 Guidance
Mar 25, 2014: LabCorp Announces Appointment of Chief Financial Officer
Feb 24, 2014: LabCorp Announces the Availability of Thermo Scientific ImmunoCAP Allergy Testing Products
Feb 07, 2014: Laboratory Corporation of America Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance
Jan 29, 2014: Epic Sciences Partners with LabCorp to Accelerate European Clinical Sample Processing for Circulating Tumor Cell Technology
Jan 21, 2014: Illumina Signs Master Supply Agreement to Provide Next-Generation Sequencing Technologies to LabCorp
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Dec 10, 2013: LabCorp Updates 2013 Guidance and Provides Preliminary 2014 Guidance
Oct 28, 2013: Garheng Kong Named to LabCorp Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Laboratory Corporation of America Holdings, Key Facts
Laboratory Corporation of America Holdings, Key Employees
Laboratory Corporation of America Holdings, Key Employee Biographies
Laboratory Corporation of America Holdings, Major Products and Services
Laboratory Corporation of America Holdings Number of Pipeline Products by Equipment Type
Laboratory Corporation of America Holdings Pipeline Products by Equipment Type
Laboratory Corporation of America Holdings Number of Pipeline Products by Development Stage
Laboratory Corporation of America Holdings Pipeline Products by Development Stage
Laboratory Corporation of America Holdings, History
Laboratory Corporation of America Holdings, Other Locations
Laboratory Corporation of America Holdings, Subsidiaries
Laboratory Corporation of America Holdings, Key Competitors
Laboratory Corporation of America Holdings, Ratios based on current share price
Laboratory Corporation of America Holdings, Annual Ratios
Laboratory Corporation of America Holdings, Interim Ratios
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Type, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Laboratory Corporation of America Holdings Pipeline Products by Equipment Type
Laboratory Corporation of America Holdings Pipeline Products by Development Stage
Laboratory Corporation of America Holdings, Performance Chart (2009 - 2013)
Laboratory Corporation of America Holdings, Ratio Charts
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Laboratory Corporation of America Holdings, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Ask Your Question

Laboratory Corporation of America Holdings (LH) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: